Declared Dividend • Jun 04
First half dividend of UK£0.028 announced Shareholders will receive a dividend of UK£0.028. Ex-date: 13th August 2026 Payment date: 4th September 2026 Dividend yield will be 1.6%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is covered by earnings (46% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 6.9% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 74% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Jun 03
Chemring Group PLC Provides Earnings Guidance for the Year 2026 Chemring Group PLC provided earnings guidance for the year 2026. Full year expectations are unchanged, supported by 91% of expected 2026 revenue either delivered or in the order book at 30 April 2026. As previously guided, operating profit is expected to be weighted c.70% to H2, reflecting scheduled programme deliveries, customer acceptance timing and the phasing of Sensors & Information contract activity and awards. Valuation Update With 7 Day Price Move • May 28
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to €6.55, the stock trades at a forward P/E ratio of 28x. Average forward P/E is 31x in the Aerospace & Defense industry in Germany. Total returns to shareholders of 128% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €9.24 per share. Annuncio • May 26
Chemring Group PLC to Report First Half, 2026 Results on Jun 02, 2026 Chemring Group PLC announced that they will report first half, 2026 results on Jun 02, 2026 Board Change • May 20
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Senior Independent Director Baroness Rock was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Annuncio • Mar 05
Chemring Group plc Announces Appointment of Baroness Kate Rock as Independent Non-Executive Director, Member of the Audit, Nomination and Remuneration Committees, Effective April 1, 2026 Chemring Group PLC announced the appointment of Baroness Kate Rock as an independent non-executive director. Upon joining the Board, Kate will become the Senior Independent Director and a member of the Audit, Nomination and Remuneration Committees. She will join the Board with effect from April 1, 2026. Kate is an experienced non-executive director with a board portfolio covering technology, engineering, construction and infrastructure. Underpinned by a strong background in corporate communications and strategy, she combines deep engineering sector knowledge with a strategic understanding of how innovation and technology enhance productivity, together with wide-ranging experience working across government. On December 1, 2022, Kate was appointed Non-Executive Chair of the UK infrastructure solutions company Costain Group PLC. Since that time Costain has seen a near five-fold increase in its share price and has re-entered the FTSE 250 index. In September 2018, she joined the Board of FTSE 250 Keller Group plc (the world's largest geotechnical specialist contractor) and is now the Senior Independent Director, serving on the Audit & Risk, Nomination & Governance, Remuneration and Sustainability Committees. Having been appointed a Life Peer in 2015, she sat on the House of Lords Science and Technology Select Committee until January 2023. She was also a member of the House of Lords Select Committee on Artificial Intelligence from 2017 to 2018 and was Chair of the House of Lords Select Committee on Autism between January and November 2025. Until January 2023, Kate was a Board member of the world's first Centre for Data Ethics and Innovation and was, until November 2017, a non-executive director of Imagination Technologies plc, the former global FTSE 250 high technology company. Annuncio • Feb 20
Chemring Group PLC Appoints Stephen King as Interim Senior Independent Director Chemring Group PLC announced that as previously announced, Fiona MacAulay, Senior Independent Director, will not be seeking re-election at today's Annual General Meeting. The process to identify a suitable candidate to replace her is progressing well. In the meantime, Stephen King, Non-Executive Director, has been appointed the Interim Senior Independent Director. Stephen will fulfil this role in addition to his role as Chair of the Audit Committee. Annuncio • Dec 10
Chemring Group PLC, Annual General Meeting, Feb 20, 2026 Chemring Group PLC, Annual General Meeting, Feb 20, 2026. Annuncio • Nov 10
Fiona Macaulay Not Stand for Re-Election to the Board of Chemring Group plc Chemring Group PLC announced Fiona MacAulay, Senior Independent Director, has informed the Board that she will not be seeking re-election at the Group's Annual General Meeting in February 2026. Fiona's second three-year term as a non-executive director would otherwise have expired on 2 June 2026. The Chairman and the Board of Directors wish to extend their due to Fiona for her considerable contribution to the Group. A process to identify a suitable candidate to replace her will now be instigated. Annuncio • Oct 07
Chemring Group PLC to Report Fiscal Year 2025 Results on Dec 09, 2025 Chemring Group PLC announced that they will report fiscal year 2025 results on Dec 09, 2025 Annuncio • Jun 30
Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million. Chemring Group PLC (LSE:CHG) agreed to acquire Landguard Nexus Limited for £20 million on June 30, 2025. The consideration will be satisfied by a £14 million cash payment on completion, funded from Chemring's existing bank facilities, and cash earnouts totaling up to £6 million subject to certain performance targets. The acquisition is expected to be marginally earnings enhancing in the year ending October 31, 2026. Following completion of the acquisition, the current owner-managers of Landguard are expected to remain with Chemring.
For the period ending January 31, 2025, Landguard Nexus Limited reported total revenue of £7 million.
Completion of the transaction is subject to approval under the UK National Investment and Security Act. Annuncio • Jun 03
Chemring Group plc Announces Interim Dividend, Payable on September 5, 2025 Chemring Group PLC has declared an interim dividend in respect of the 2025 financial year of 2.7 pence (first half of 2024: 2.6 pence) per ordinary share which will be paid on 5 September 2025 to shareholders on the register on 15 August 2025. Annuncio • Feb 26
Chemring Group PLC to Report First Half, 2025 Results on Jun 03, 2025 Chemring Group PLC announced that they will report first half, 2025 results on Jun 03, 2025 Declared Dividend • Dec 30
Final dividend of UK£0.052 announced Shareholders will receive a dividend of UK£0.052. Ex-date: 20th March 2025 Payment date: 11th April 2025 Dividend yield will be 2.1%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is covered by earnings (50% earnings payout ratio) but not covered by cash flows (187% cash payout ratio). The dividend has increased over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Annuncio • Dec 20
Chemring Group PLC, Annual General Meeting, Feb 26, 2025 Chemring Group PLC, Annual General Meeting, Feb 26, 2025. Annuncio • Dec 17
Chemring Group PLC Recommends Final Dividend for the Year Ended 31 October, 2024, Payable on 11 April 2025 The Board of Chemring Group PLC is recommending a final dividend in respect of the year to 31 October 2024 of 5.2 pence (2023: 4.6 pence) per ordinary share. The estimated cash value of this dividend is £14.5 million. With the interim dividend of 2.6 pence per share (2023: 2.3 pence), this results in a total dividend of 7.8 pence (2023: 6.9 pence) per ordinary share. If approved, the final dividend will be paid on 11 April 2025 to shareholders on the register on 21 March 2025. In accordance with accounting standards, this final dividend has not been recorded as a liability as at 31 October 2024. Annuncio • Dec 05
Chemring Group Announces Board Changes Chemring announced that Andrew Davies, who has been a non-executive director since May 2016 and the Senior Independent Director since May 2020, will retire from the Board on 31 January 2025, having approached the end of his nine-year term, and will not therefore seek re-election at the 2025 Annual General Meeting. As previously indicated in the 2023 annual report, Fiona MacAulay, who has been a non-executive director since June 2020, will succeed Andrew as the Senior Independent Director. Annuncio • Oct 17
Chemring Group PLC to Report Fiscal Year 2024 Results on Dec 17, 2024 Chemring Group PLC announced that they will report fiscal year 2024 results on Dec 17, 2024 Upcoming Dividend • Aug 08
Upcoming dividend of UK£0.026 per share Eligible shareholders must have bought the stock before 15 August 2024. Payment date: 06 September 2024. Payout ratio is a comfortable 64% but the company is paying out more than the cash it is generating. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.0%). Annuncio • Jun 24
Chemring Group plc Announces Board Changes Chemring Group PLC announced the appointment of Tony Wood as an independent non-executive director and Chairman-designate. He joins the Board with effect from October 1, 2024 and will succeed Carl-Peter Forster as Chairman of the Board on 1 December 2024, following Carl-Peter's retirement on November 30, 2024. Carl-Peter joined the Board of Chemring on 1 May 2016 and was appointed Chairman on July 1, 2016. Since then he has successfully led the Group through a period of significant transformation as they have built a stronger, higher-quality and more resilient business. The investments made in both culture and infrastructure position the Group well to capitalise on its many opportunities. Tony is a member of the Board of Directors of Airbus SE, the CAC 40 aerospace and defence firm, and National Grid plc, an energy company operating in the UK and the US. From 2018-2022 he was Chief Executive of FTSE 100 Meggitt plc, where he led the operational and cultural transformation of the company. He brings to the Board significant engineering and sector experience having also been a Non-Executive Director and former President of ADS Group Limited, the trade association for the Aerospace, Defence, Security and Space sectors in the UK, from 2020-2023. Prior to joining Meggitt he spent 15 years at Rolls-Royce plc, latterly serving as President of Aerospace from 2013-2016. Tony holds a degree in Engineering from the Open University in the UK and a Master of Business Administration from INSEAD in France. He is a Fellow of the Royal Aeronautical Society and a Fellow of the Association for Project Management. New Risk • Jun 05
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.4% Last year net profit margin: 9.1% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (172% cash payout ratio). Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (6.4% net profit margin). Significant insider selling over the past 3 months (€1.1m sold). Reported Earnings • Jun 05
First half 2024 earnings released: EPS: UK£0.045 (vs UK£0.066 in 1H 2023) First half 2024 results: EPS: UK£0.045 (down from UK£0.066 in 1H 2023). Revenue: UK£223.4m (up 5.3% from 1H 2023). Net income: UK£12.2m (down 35% from 1H 2023). Profit margin: 5.5% (down from 8.8% in 1H 2023). Revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 11% per year, which means it is well ahead of earnings. Recent Insider Transactions • Mar 27
Group Chief Executive & Director recently sold €577k worth of stock On the 22nd of March, Michael Ord sold around 138k shares on-market at roughly €4.17 per share. This transaction amounted to 30% of their direct individual holding at the time of the trade. In the last 3 months, they made an even bigger sale worth €778k. Michael has been a net seller over the last 12 months, reducing personal holdings by €1.4m. Upcoming Dividend • Mar 14
Upcoming dividend of UK£0.046 per share Eligible shareholders must have bought the stock before 21 March 2024. Payment date: 12 April 2024. Payout ratio is a comfortable 52% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (5.0%). Higher than average of industry peers (1.0%). New Risk • Jan 18
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: €847k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Significant insider selling over the past 3 months (€847k sold). Recent Insider Transactions • Jan 17
Group Chief Executive & Director recently sold €778k worth of stock On the 15th of January, Michael Ord sold around 192k shares on-market at roughly €4.05 per share. This transaction amounted to 29% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Annuncio • Jan 10
Chemring Group PLC to Report First Half, 2024 Results on Jun 04, 2024 Chemring Group PLC announced that they will report first half, 2024 results on Jun 04, 2024 New Risk • Dec 20
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 33% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Reported Earnings • Dec 13
Full year 2023 earnings released: EPS: UK£0.13 (vs UK£0.17 in FY 2022) Full year 2023 results: EPS: UK£0.13 (down from UK£0.17 in FY 2022). Revenue: UK£472.6m (up 6.7% from FY 2022). Net income: UK£37.7m (down 21% from FY 2022). Profit margin: 8.0% (down from 11% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.5% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has increased by 5% per year. Buying Opportunity • Nov 15
Now 20% undervalued Over the last 90 days, the stock is up 3.0%. The fair value is estimated to be €4.26, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.0% over the last 3 years. Earnings per share has grown by 8.6%. For the next 3 years, revenue is forecast to grow by 8.4% per annum. Earnings is also forecast to grow by 19% per annum over the same time period. Annuncio • Sep 12
Chemring Group PLC Provides Revenue Guidance for the Year Ending 31 October 2023 Chemring Group PLC provided revenue guidance for the year ending 31 October 2023. Expected fiscal year 2023 revenue is now fully covered by the order book and the outturn for the year ending 31 October 2023 remains in line with the Board's and current analyst expectations. Achieving full year expectations is subject to US Department of Defense ("US DoD") approval of certain countermeasure deliveries, representing c.£25m of revenue, that have already been manufactured and will be recognised once approval is received. Upcoming Dividend • Aug 10
Upcoming dividend of UK£0.023 per share at 2.0% yield Eligible shareholders must have bought the stock before 17 August 2023. Payment date: 08 September 2023. Payout ratio is a comfortable 43% and this is well supported by cash flows. Trailing yield: 2.0%. Lower than top quartile of German dividend payers (4.7%). Higher than average of industry peers (1.5%). Board Change • Jul 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 7 experienced directors. 1 highly experienced director. Independent Non Executive Director Alpna Amar was the last director to join the board, commencing their role in 2023. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Annuncio • Jun 13
Chemring Group plc Announces Appointment of Alpna Amar as an Independent Non-Executive Director with Immediate Effect Chemring Group PLC announced the appointment of Alpna Amar as an independent non-executive director. She will join the Board with immediate effect. Alpna (age 43) is currently Corporate Development Director of Kier Group plc and has been a member of Kier Group's Executive Committee since May 2021. A qualified Chartered Accountant, Alpna has over 22 years of corporate, operational and commercial finance, strategy, M&A and investor relations experience in both corporate and consulting positions. Prior to Kier Group she held senior investor relations and corporate development roles at global automotive suppliers, TI Fluid Systems plc and International Automotive Components Group SA. Alpna is a fellow of the Institute of Chartered Accountants of England and Wales and has a degree in Economics and Politics from Lancaster University. Upon joining the Board, Alpna Amar will become a member of the Audit and Nomination Committees. Reported Earnings • Jun 06
First half 2023 earnings released: EPS: UK£0.066 (vs UK£0.095 in 1H 2022) First half 2023 results: EPS: UK£0.066 (down from UK£0.095 in 1H 2022). Revenue: UK£212.1m (down 3.8% from 1H 2022). Net income: UK£18.7m (down 29% from 1H 2022). Profit margin: 8.8% (down from 12% in 1H 2022). Revenue is forecast to grow 7.4% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Annuncio • May 25
Chemring Group plc Announces Appointment of James Mortensen as Chief Financial Officer Chemring Group PLC announced appointment of James Mortensen as Chief Financial Officer. James has a proven track record in industrial, engineering and technology sectors with extensive experience in building and managing global, multi-disciplinary finance teams. He joins Chemring from Smiths Group plc ("Smiths"), the FTSE 100 engineering group where he has spent the last seven years. James joined the Smiths M&A team in 2016 and, having played a key role in scaling ventilator manufacturing during COVID for the UK Government, he became Chief Financial Officer of the $1.1bn revenue Smiths Medical Division in 2020. He held this role until the sale of Smiths Medical for $2.7bn in February 2022, having also prepared the business for a London listing. He is currently Group Head of Corporate Development with responsibility for sourcing, evaluating and executing acquisitions across the four major global markets where Smiths operate: Security & Defence, Aerospace, General Industry and Energy. Prior to Smiths James spent eight years at Smith & Nephew plc, the FTSE 100 medical technology company where he held progressively senior finance roles in the areas of group reporting, strategic planning and corporate finance. Having graduated from Bristol University James started his career at KPMG in their audit practice and is a fellow of the Institute of Chartered Accountants of England and Wales. James will take over from Andrew Lewis, who announced his intention to retire on 23 January 2023 and whose notice period runs until 22 January 2024. The Group is working with James to agree the date on which he will join Chemring. A further announcement will be made in due course. Buying Opportunity • Apr 14
Now 22% undervalued Over the last 90 days, the stock is up 3.8%. The fair value is estimated to be €4.18, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.5% per annum. Earnings is also forecast to grow by 5.7% per annum over the same time period. Upcoming Dividend • Mar 16
Upcoming dividend of UK£0.038 per share at 2.1% yield Eligible shareholders must have bought the stock before 23 March 2023. Payment date: 14 April 2023. Payout ratio is a comfortable 34% and this is well supported by cash flows. Trailing yield: 2.1%. Lower than top quartile of German dividend payers (4.8%). Higher than average of industry peers (1.3%). Annuncio • Feb 01
Chemring Group PLC to Report Q2, 2023 Results on Jun 06, 2023 Chemring Group PLC announced that they will report Q2, 2023 results on Jun 06, 2023 Recent Insider Transactions • Jan 29
Independent Non-Executive Director recently bought €209k worth of stock On the 24th of January, Stephen King bought around 65k shares on-market at roughly €3.22 per share. This transaction increased Stephen's direct individual holding by 2x at the time of the trade. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold €3.1m more in shares than they bought in the last 12 months. Recent Insider Transactions • Dec 22
CFO & Director recently sold €1.2m worth of stock On the 19th of December, Andrew Lewis sold around 339k shares on-market at roughly €3.46 per share. This transaction amounted to 53% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Andrew has been a net seller over the last 12 months, reducing personal holdings by €1.9m. Buying Opportunity • Dec 16
Now 21% undervalued after recent price drop Over the last 90 days, the stock is down 1.2%. The fair value is estimated to be €4.29, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.1% over the last 3 years. Earnings per share has grown by 18%. For the next 3 years, revenue is forecast to grow by 4.3% per annum. Earnings is also forecast to grow by 6.1% per annum over the same time period. Reported Earnings • Dec 15
Full year 2022 earnings released: EPS: UK£0.17 (vs UK£0.15 in FY 2021) Full year 2022 results: EPS: UK£0.17 (up from UK£0.15 in FY 2021). Revenue: UK£442.8m (up 13% from FY 2021). Net income: UK£47.4m (up 14% from FY 2021). Profit margin: 11% (in line with FY 2021). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Aerospace & Defense industry in Germany. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Independent Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Oct 07
Investor sentiment improved over the past week After last week's 16% share price gain to €3.60, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 19x in the Aerospace & Defense industry in Germany. Total returns to shareholders of 73% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.16 per share. Annuncio • Sep 13
Chemring Group PLC to Report Fiscal Year 2022 Results on Dec 13, 2022 Chemring Group PLC announced that they will report fiscal year 2022 results at 7:00 AM, Coordinated Universal Time on Dec 13, 2022 Board Change • Sep 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Independent Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Upcoming Dividend • Aug 11
Upcoming dividend of UK£0.019 per share Eligible shareholders must have bought the stock before 18 August 2022. Payment date: 09 September 2022. Payout ratio is a comfortable 31% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (4.5%). In line with average of industry peers (1.4%). Recent Insider Transactions • Jul 15
Group Legal Director recently sold €69k worth of stock On the 11th of July, Sarah Ellard sold around 18k shares on-market at roughly €3.82 per share. In the last 3 months, there was an even bigger sale from another insider worth €74k. Insiders have been net sellers, collectively disposing of €1.5m more than they bought in the last 12 months. Reported Earnings • Jun 09
First half 2022 earnings released First half 2022 results: Revenue: (down 100% from 1H 2021). Net income: (down UK£21.4m from profit in 1H 2021). Profit margin: (down from 11% in 1H 2021). The decrease in margin was driven by lower expenses. Over the next year, revenue is forecast to grow 7.9%, compared to a 38% growth forecast for the industry in Germany. Recent Insider Transactions • Mar 17
Group Finance Director & Director recently sold €71k worth of stock On the 14th of March, Andrew Lewis sold around 18k shares on-market at roughly €3.97 per share. This was the largest sale by an insider in the last 3 months. This was Andrew's only on-market trade for the last 12 months. Annuncio • Mar 04
Chemring Group PLC to Report First Half, 2022 Results on Jun 08, 2022 Chemring Group PLC announced that they will report first half, 2022 results on Jun 08, 2022 Upcoming Dividend • Mar 03
Upcoming dividend of UK£0.032 per share Eligible shareholders must have bought the stock before 10 March 2022. Payment date: 31 March 2022. Payout ratio is a comfortable 33% and this is well supported by cash flows. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.4%). Higher than average of industry peers (1.1%). Valuation Update With 7 Day Price Move • Mar 01
Investor sentiment improved over the past week After last week's 30% share price gain to €3.88, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 21x in the Aerospace & Defense industry in Germany. Total returns to shareholders of 135% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €6.14 per share. Reported Earnings • Dec 15
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Full year 2021 results: EPS: UK£0.15 (up from UK£0.12 in FY 2020). Revenue: UK£393.3m (down 2.3% from FY 2020). Net income: UK£41.5m (up 20% from FY 2020). Profit margin: 11% (up from 8.6% in FY 2020). The increase in margin was driven by lower expenses. Revenue missed analyst estimates by 4.1%. Over the next year, revenue is forecast to grow 8.2%, compared to a 24% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 12
Upcoming dividend of UK£0.016 per share Eligible shareholders must have bought the stock before 19 August 2021. Payment date: 10 September 2021. Trailing yield: 1.3%. Lower than top quartile of German dividend payers (3.1%). Lower than average of industry peers (1.6%). Board Change • Jul 31
High number of new directors Non-Executive Director Fiona MacAulay was the last director to join the board, commencing their role in 2020. Recent Insider Transactions • Jul 22
Group Chief Executive & Director recently sold €540k worth of stock On the 19th of July, Michael Ord sold around 165k shares on-market at roughly €3.27 per share. This was the largest sale by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months. Reported Earnings • Jun 05
First half 2021 earnings released: EPS UK£0.076 (vs UK£0.058 in 1H 2020) The company reported a strong first half result with improved earnings, revenues and profit margins. First half 2021 results: Revenue: UK£198.5m (up 3.9% from 1H 2020). Net income: UK£21.4m (up 31% from 1H 2020). Profit margin: 11% (up from 8.5% in 1H 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 101% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Annuncio • Jun 04
Chemring Group PLC (LSE:CHG) acquired Cubica Group. Chemring Group PLC (LSE:CHG) acquired Cubica Group on June 3, 2021. he consideration will be satisfied by a payment in cash on completion and a deferred consideration payable in Chemring 1p ordinary shares in two tranches on the second and third anniversary of completion. The transaction is financed from Chemring's existing bank facilities. Current owners of Cubica and Q6 Holdings Limited collectively Cubica Group will remain in employment with Chemring following completion of the Acquisition.
Chemring Group PLC (LSE:CHG) completed the acquisition of Cubica Group on June 3, 2021. Upcoming Dividend • Mar 25
Upcoming dividend of UK£0.026 per share Eligible shareholders must have bought the stock before 01 April 2021. Payment date: 23 April 2021. Trailing yield: 1.5%. Lower than top quartile of German dividend payers (3.3%). In line with average of industry peers (1.6%). Annuncio • Mar 03
Chemring Group PLC to Report First Half, 2021 Results on Jun 03, 2021 Chemring Group PLC announced that they will report first half, 2021 results on Jun 03, 2021 Is New 90 Day High Low • Jan 08
New 90-day high: €3.29 The company is up 18% from its price of €2.79 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 29% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.69 per share. Annuncio • Dec 17
Chemring Group PLC, Annual General Meeting, Mar 04, 2021 Chemring Group PLC, Annual General Meeting, Mar 04, 2021. Is New 90 Day High Low • Dec 16
New 90-day high: €3.25 The company is up 18% from its price of €2.76 on 17 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €2.70 per share. Reported Earnings • Dec 16
Full year 2020 earnings released: EPS UK£0.12 The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: UK£402.5m (up 20% from FY 2019). Net income: UK£34.7m (up 50% from FY 2019). Profit margin: 8.6% (up from 6.9% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 93% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Analyst Estimate Surprise Post Earnings • Dec 16
Revenue beats expectations Revenue exceeded analyst estimates by 3.3%. Over the next year, revenue is forecast to grow 3.9%, compared to a 12% growth forecast for the Aerospace & Defense industry in Germany. Is New 90 Day High Low • Nov 14
New 90-day high: €2.96 The company is up 4.0% from its price of €2.84 on 14 August 2020. The German market is up 1.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Aerospace & Defense industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €1.42 per share. Annuncio • Nov 05
Chemring Group plc Announces its UK Subsidiary, Chemring Countermeasures UK Receives Contracts Worth £25.8 Million Chemring announced that in the final month of its financial year, its UK subsidiary, Chemring Countermeasures UK, has been awarded contracts worth £25.8 million from the UK MOD to develop and supply naval countermeasures in support of the Royal Navy. Deliveries under these contracts will be made in FY21 through to FY23. CCM UK has also received a £5.5 million contract from the UK MOD to manufacture air countermeasures in support of the UK armed forces. Deliveries under this contract will be made during FY21 and FY22. All work under these contracts will be performed at CCM UK's Salisbury facility. Is New 90 Day High Low • Oct 24
New 90-day high: €2.94 The company is up 16% from its price of €2.52 on 24 July 2020. The German market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Aerospace & Defense industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €0.71 per share. Annuncio • Jul 31
Nammo AS completed the acquisition of Chemring Ordnance, Inc. from Chemring Group PLC (LSE:CHG). Nammo AS signed a conditional agreement to acquire Chemring Ordnance, Inc. from Chemring Group PLC (LSE:CHG) for $17 million on November 21, 2019. The consideration will be paid in cash on completion and is subject to a working capital adjustment. In the year ended 31 October 2018, Chemring Ordnance generated revenue of $57 million, an underlying operating loss of $0.2 million, had gross assets of $20.5 million and net assets of $11.3 million. The transaction is subject to regulatory approval by the US authorities, is expected to complete no later than the end of second quarter of 2020. As of May 7, 2020, Chemring is pleased to announce that all regulatory approvals have now been received. The proceeds after costs will be used by the Group for general corporate purposes. KippsDeSanto & Co. acted as the financial advisor to Chemring Group PLC (LSE:CHG)
Nammo AS completed the acquisition of Chemring Ordnance, Inc. from Chemring Group PLC (LSE:CHG) on May 7, 2020.